cTnI+CK-MB+Myo

Immunofluorescence-based combined test kit for simultaneous detection of cardiac biomarkers cTnI, CK-MB, and myoglobin. Designed for rapid cardiac injury assessment in acute coronary syndrome diagnosis and risk stratification. Enables multi-marker analysis from a single sample for improved clinical decision-making.

A quantitative test kit for simultaneous measurement of cardiac troponin I (cTnI), creatine kinase-MB (CK-MB), and myoglobin (MYO) levels in patient samples using TRFIA methodology.

Rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin, and creatine kinase-MB (CK-MB) markers. Designed for quick diagnosis of acute myocardial infarction and cardiac injury in clinical and emergency settings. Delivers results in minutes to support timely patient management.

A combination rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin (Myo), and creatine kinase-MB (CK-MB). This multiplex test supports cardiac biomarker assessment for heart attack and myocardial injury detection.

Multiplex rapid test for simultaneous detection of cardiac troponin I, myoglobin, and CK-MB. Comprehensive cardiac marker panel for acute coronary syndrome evaluation.

A multiplex rapid test for simultaneously detecting cardiac troponin I, myoglobin, and creatine kinase-MB. Provides comprehensive cardiac marker assessment for heart damage and stress evaluation.

An immunoassay diagnostic test for myoglobin detection that enables one sample, one run testing on a single instrument to increase efficiency in triaging chest pain patients. Myoglobin is a protein that reflects myocardial necrosis and can be used for early diagnosis of myocardial infarction. When combined with troponin I (cTnI) and creatine kinase isoenzyme (CK-MB), it has great value in early diagnosis of acute myocardial infarction.

A cardiac marker test for creatine kinase-MB, myoglobin, and troponin I.

This product is used for quantitative determination of troponin I (cTnI), creatine kinase isoenzyme (CK-MB), and myoglobin (Myo) in human serum, plasma, and whole blood in vitro.

Uses highly specific antigen-antibody reactions and immunochromatographic analysis technology with colloidal gold-labeled rapid solid-phase immunochromatography to qualitatively detect CTnI, CK-MB, and MYO markers in whole blood, serum, and plasma. The simultaneous detection of three markers provides greater clinical reference significance.

A rapid immunochromatographic assay using colloidal gold-labeled fixed-phase technology to qualitatively detect CTnI, CK-MB, and MYO markers in whole blood, serum, or plasma. The triple simultaneous detection provides greater clinical diagnostic significance for cardiac assessment.

Immunochemical assays for troponin, myoglobin, and other cardiac markers in acute care settings. Enables rapid diagnosis of myocardial infarction and cardiac injury.